Moderna is the latest company to produce a promising RSV vaccine
January 18, 2023 at 12:23 PM EST
The experimental respiratory syncytial virus vaccine prevented most infections in older adults in a Phase 3 clinical trial
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|